<li>goserelin<p>goserelin increases toxicity of escitalopram by QTc interval. Contraindicated. Increases risk of torsades de pointes.</p></li><li>isocarboxazid<p>isocarboxazid and escitalopram both increase  serotonin levels. Contraindicated.</p></li><li>leuprolide<p>leuprolide increases toxicity of escitalopram by QTc interval. Contraindicated. Increases risk of torsades de pointes.</p></li><li>phenelzine<p>phenelzine and escitalopram both increase  serotonin levels. Contraindicated.</p></li><li>procarbazine<p>procarbazine and escitalopram both increase  serotonin levels. Contraindicated. Combination is contraindicated within 2 weeks of MAOI use.</p></li><li>selegiline<p>selegiline and escitalopram both increase  serotonin levels. Contraindicated. At least 14 days should elapse between discontinuation of selegiline and initiation of treatment with a serotonergic drug.</p></li><li>tranylcypromine<p>tranylcypromine and escitalopram both increase  serotonin levels. Contraindicated.</p></li><li>ziprasidone<p>escitalopram and ziprasidone both increase  QTc interval. Contraindicated.<span><br><br></span>ziprasidone and escitalopram both increase  QTc interval. Contraindicated.</p></li>